Press & news

FluoGuide develops surgical solutions that is expected to reduce suffering for the patient and increases the likelihood of cure as well as reducing costs for the health care system.

Selected as best IPO in 2019

FluoGuide won the 2019 share price development award in the micro-cap category and also received the honorary quality award (Affärsvärlden’s IPO Guide).

FluoGuide A/S: Change of report date

Press release


November 25, 2019

FluoGuide A/S will publish its interim report for third quarter 2019 on 29 November 2019. Previously communicated date was 30 November 2019.

30 November is a Saturday and the report date is therefore changed to Friday, 29 November 2019.

 

For further information, please contact:
Morten Albrechtsen, CEO
Telephone: +45 24 25 62 66
E-mail: ma@fluoguide.com